Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

  title={Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?},
  author={F{\'a}bio Gabriel Teixeira and Miguel M. Carvalho and Nuno Sousa and Ant{\'o}nio Jos{\'e} Salgado},
  journal={Cellular and Molecular Life Sciences},
The low regeneration potential of the central nervous system (CNS) represents a challenge for the development of new therapeutic strategies. Mesenchymal stem cells (MSCs) have been proposed as a possible therapeutic tool for CNS disorders. In addition to their differentiation potential, it is well accepted nowadays that their beneficial actions can also be mediated by their secretome. Indeed, it was already demonstrated, both in vitro and in vivo, that MSCs are able to secrete a broad range of… 

Exploring the secretome of mesenchymal like stem cells for central nervous system regenerative medicine: a focus on Parkinson's disease

The scope of the present thesis was to explore the potential of the sole use of different tissue derived MSCs secretome, namely derived from bone marrow, adipose tissue and the Wharton jelly surrounding the vessels of the umbilical cord for CNS regenerative medicine, namely in PD.

The stem cell secretome and its role in brain repair

Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF

It is demonstrated that application of MSCs secretome to both rat cortical and hippocampal neurons induces an increase in axonal length and this growth effect is axonal intrinsic with no contribution from the cell body.

Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders

The potential of MSCs as a therapeutic tool to treat neurological disorders is focused on, summarizing the state of the art of this topic and the most recent clinical studies.

Modulation of the Mesenchymal Stem Cell Secretome Using Computer-Controlled Bioreactors: Impact on Neuronal Cell Proliferation, Survival and Differentiation

Data is presented indicating that the use of computer-controlled suspension bioreactors enhanced the neuroregulatory profile of hMSCs secretome, and the appropriate use of dynamic culture conditions can represent an important asset for the development of future neuro-regenerative strategies involving the use.

Cell Secretome: Basic Insights and Therapeutic Opportunities for CNS Disorders

The present review discusses the current state of the art of secretome-based therapy applications in different central nervous system (CNS) pathologies and aims to clarify some of the main questions that currently exist in the field of secretomes-based therapies and consequently gain new knowledge that may help in the clinical application ofsecretome in CNS disorders.

Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities

The use of MSCs, and their secretome, become a strong candidate to be used as a therapeutic tool for CNS applications, namely by triggering the endogenous proliferation and differentiation of neural progenitors, among other mechanisms.



Role of mesenchymal stem cells in neurogenesis and nervous system repair

Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy

Encouraging results indicate that MSC-MVs have similar protective and reparative properties as their cellular counterparts in tissue repair and possibly anti-cancer therapy, and represent a promising opportunity to develop novel cell-free therapy approaches that might overcome the obstacles and risks associated with the use of native or engineered stem cells.

Neuroprotective features of mesenchymal stem cells.

Mesenchymal stem cells for the treatment of neurodegenerative disease.

MSCs transplanted into the brain have been demonstrated to promote functional recovery by producing trophic factors that induce survival and regeneration of host neurons, and proposed regenerative approaches to neurological diseases using MSCs include cell therapies in which cells are delivered via intracerebral or intrathecal injection.

Biochemical Heterogeneity of Mesenchymal Stem Cell Populations: Clues to their Therapeutic Efficacy

Analysis of the MSC transcriptome has led to the identification of sub populations that express a variety of regulatory proteins that function in angiogenesis, hematopoiesis, neural activities, and immunity and defense.

Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases

Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke

The Stem Cell Niche Should be a Key Issue for Cell Therapy in Regenerative Medicine

The need for a deeper understanding of the identity of this cell type and its microenvironment is discussed in order to improve the effectiveness of any cell therapy for regenerative medicine.

Mesenchymal stem cells: new approaches for the treatment of neurological diseases.

MSCs represent a promising new approach to treating diseases of the central nervous system that are traditionally associated with morbid outcomes and with additional pre-clinical and clinical studies that focus on their potential benefits as well as dangers, they may one day find translation to clinical use in the setting of neurological disease.